Morbidity Rate

In insurance, the morbidity rate refers to the frequency of illness or disease within a particular population. More specifically, it is the rate at which individuals within a specific group become ill or develop a particular disease over a given period of time. The morbidity rate is an important factor in determining insurance rates and policies.

Here are some key features of morbidity rate:

• The morbidity rate is calculated by dividing the number of people who have developed a particular disease or illness by the total number of people in the population being studied.

• The morbidity rate is typically expressed as a percentage or a rate per 1,000 or 100,000 individuals.

• The morbidity rate can be influenced by a variety of factors, including age, gender, lifestyle, and environmental factors.

• Insurers use morbidity rates to help determine premiums and to assess the risk of providing coverage to a particular group of individuals.

• Morbidity rates can also be used to identify patterns of disease and to help develop strategies for prevention and treatment.

For example, an insurance company might use morbidity rates to assess the risk of providing coverage for a particular group of individuals, such as smokers or individuals with a history of heart disease. If the morbidity rate for a particular group is high, the insurer may charge higher premiums or offer less coverage to mitigate their risk. Similarly, public health officials may use morbidity rates to identify areas where a particular disease is more prevalent and to develop strategies for prevention and treatment.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.